Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADUS Addus HomeCare	$110.92 0.0%	$112.46	$88.96 ▼ $136.72	$2.04B	0.81	195,350 shs	1,366 shs
ARDT Ardent Health	$14.25 +0.5%	$14.00	$11.31 ▼ $20.72	$2.04B	N/A	379,125 shs	6,687 shs
INNV InnovAge	$4.07 -1.7%	$3.92	$2.60 ▼ $6.69	$551.52M	0.51	50,858 shs	455 shs
PGNY Progyny	$23.23 +0.1%	$21.81	$13.39 ▼ $30.42	$1.99B	1.31	1.72 million shs	26,424 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADUS Addus HomeCare	0.00%	-0.84%	-1.67%	+8.56%	-8.25%
ARDT Ardent Health	0.00%	+6.16%	+7.99%	+13.34%	+1,418,999,900.00%
INNV InnovAge	0.00%	-6.55%	+16.95%	+46.29%	-27.37%
PGNY Progyny	0.00%	+8.21%	+10.37%	+5.12%	-19.83%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADUS Addus HomeCare	4.9782 of 5 stars	3.6	4.0	5.0	3.6	2.5	3.1
ARDT Ardent Health	3.3446 of 5 stars	3.5	0.0	0.0	2.2	0.0	3.1
INNV InnovAge	1.0137 of 5 stars	1.8	2.0	0.0	2.2	1.7	0.6
PGNY Progyny	1.0905 of 5 stars	1.3	1.0	0.0	2.7	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADUS Addus HomeCare	3.25	Buy	$142.57	28.54% Upside
ARDT Ardent Health	3.00	Buy	$20.67	45.08% Upside
INNV InnovAge	1.50	Reduce	$5.00	22.85% Upside
PGNY Progyny	2.67	Moderate Buy	$24.09	3.71% Upside

Current Analyst Ratings Breakdown

Latest INNV, ARDT, ADUS, and PGNY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/8/2025	PGNY Progyny	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/8/2025	PGNY Progyny	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$28.00
6/20/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00
6/10/2025	ADUS Addus HomeCare	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$133.00
5/20/2025	ARDT Ardent Health	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$21.00 ➝ $21.00
5/15/2025	ARDT Ardent Health	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$21.00 ➝ $21.00
5/12/2025	PGNY Progyny	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$23.00 ➝ $21.00
5/9/2025	ARDT Ardent Health	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$16.00 ➝ $18.00
5/8/2025	ADUS Addus HomeCare	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$129.00 ➝ $133.00
4/22/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00 ➝ $150.00

(Data available from 7/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADUS Addus HomeCare	$1.15B	1.77	$5.39 per share	20.58	$53.52 per share	2.07
ARDT Ardent Health	$5.97B	0.34	$2.55 per share	5.59	$10.66 per share	1.34
INNV InnovAge	$763.85M	0.72	N/A	N/A	$2.04 per share	2.00
PGNY Progyny	$1.17B	1.71	$0.35 per share	67.26	$4.96 per share	4.68

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADUS Addus HomeCare	$73.60M	$4.43	25.05	20.69	1.57	6.52%	9.23%	6.96%	8/4/2025 (Estimated)
ARDT Ardent Health	$210.34M	$1.63	8.76	7.27	1.28	3.73%	16.07%	4.69%	8/13/2025 (Estimated)
INNV InnovAge	-$21.34M	-$0.23	N/A	67.83	N/A	-3.75%	-11.91%	-5.85%	9/9/2025 (Estimated)
PGNY Progyny	$54.34M	$0.57	40.72	35.74	2.39	4.33%	10.90%	7.20%	8/5/2025 (Estimated)

Latest INNV, ARDT, ADUS, and PGNY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	PGNY Progyny	$0.42	N/A	N/A	N/A	$315.70 million	N/A
8/4/2025	Q2 2025	ADUS Addus HomeCare	$1.45	N/A	N/A	N/A	$345.71 million	N/A
5/8/2025	Q1 2025	PGNY Progyny	$0.45	$0.17	-$0.28	$0.17	$307.86 million	$324.04 million
5/6/2025	Q1 2025	ARDT Ardent Health	$0.21	$0.29	+$0.08	$0.29	$1.50 billion	$1.50 billion
5/6/2025	Q3 2025	INNV InnovAge	-$0.02	-$0.08	-$0.06	-$0.08	$214.09 million	$218.14 million
5/5/2025	Q1 2025	ADUS Addus HomeCare	$1.33	$1.42	+$0.09	$1.16	$341.66 million	$337.71 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADUS Addus HomeCare	N/A	N/A	N/A	N/A	N/A
ARDT Ardent Health	N/A	N/A	N/A	N/A	N/A
INNV InnovAge	N/A	N/A	N/A	N/A	N/A
PGNY Progyny	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADUS Addus HomeCare	0.20	1.74	1.74
ARDT Ardent Health	0.70	2.12	1.98
INNV InnovAge	0.04	0.78	0.78
PGNY Progyny	N/A	2.39	2.39

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADUS Addus HomeCare	95.35%
ARDT Ardent Health	N/A
INNV InnovAge	12.26%
PGNY Progyny	94.93%

Insider Ownership

Company	Insider Ownership
ADUS Addus HomeCare	4.60%
ARDT Ardent Health	1.70%
INNV InnovAge	1.40%
PGNY Progyny	9.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADUS Addus HomeCare	49,703	18.40 million	17.55 million	Optionable
ARDT Ardent Health	24,900	143.04 million	140.61 million	Optionable
INNV InnovAge	2,350	135.01 million	133.12 million	Optionable
PGNY Progyny	310	85.72 million	77.66 million	Optionable

INNV, ARDT, ADUS, and PGNY Headlines

Recent News About These Companies

Principal Financial Group Inc. Raises Stake in Progyny, Inc. (NASDAQ:PGNY)

July 14 at 3:51 AM | marketbeat.com

Leerink Partnrs Has Bullish Estimate for Progyny Q2 Earnings

July 13 at 2:17 AM | americanbankingnews.com

Progyny, Inc. Partners with ŌURA to Enhance Women's Health ... - Nasdaq

July 12 at 7:44 AM | nasdaq.com

FY2026 EPS Estimates for Progyny Lifted by Leerink Partnrs

July 12 at 2:46 AM | americanbankingnews.com

Leerink Partnrs Has Bullish Forecast for Progyny Q2 Earnings

July 11 at 5:48 AM | marketbeat.com

Progyny, Inc. Partners with ŌURA to Enhance Women's Health Insights Through Wearable Technology

July 10, 2025 | quiverquant.comQ

Analysts Set Expectations for Progyny FY2026 Earnings

July 10, 2025 | marketbeat.com

Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause

July 10, 2025 | globenewswire.com

Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report - Nasdaq

July 10, 2025 | nasdaq.com

Progyny, Inc. Secures $200 Million Credit Facility to Enhance Financial Flexibility and Anticipates Positive Second Quarter Results - Nasdaq

July 10, 2025 | nasdaq.com

Which Is a Better Investment, Addus HomeCare Corporation or Progyny, Inc. Stock?

July 9, 2025 | aaii.comA

1 Value Stock with Impressive Fundamentals and 2 to Turn Down

July 9, 2025 | finance.yahoo.com

Which Is a Better Investment, Progyny, Inc. or GeneDx Holdings Corp. Stock?

July 9, 2025 | aaii.comA

Leerink Partners Upgrades Progyny (PGNY)

July 9, 2025 | msn.com

Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength?

July 9, 2025 | zacks.com

Progyny (NASDAQ:PGNY) Raised to "Strong-Buy" at Leerink Partnrs

July 9, 2025 | marketbeat.com

Progyny rises on guidance update

July 8, 2025 | msn.com

Progyny (NASDAQ:PGNY) Trading 7.1% Higher - Here's Why

July 8, 2025 | marketbeat.com

Leerink Partners Upgrades Progyny (NASDAQ:PGNY) to "Outperform"

July 8, 2025 | marketbeat.com

Progyny, Inc. Secures $200 Million Credit Facility to Enhance Financial Flexibility and Anticipates Positive Second Quarter Results

July 8, 2025 | quiverquant.comQ

Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report

July 8, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

INNV, ARDT, ADUS, and PGNY Company Descriptions

Addus HomeCare NASDAQ:ADUS

$110.92 -0.01 (0.00%)

As of 10:02 AM Eastern

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Ardent Health NYSE:ARDT

$14.24 +0.08 (+0.53%)

As of 10:02 AM Eastern

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

InnovAge NASDAQ:INNV

$4.07 -0.07 (-1.69%)

As of 10:02 AM Eastern

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

Progyny NASDAQ:PGNY

$23.23 +0.02 (+0.09%)

As of 10:01 AM Eastern

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time